ALL-073: Targeting CD38 With Daratumumab in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Systematic Review
Year: 2026
Type: conference-abstract
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7204727122
